Loading...
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer
Classifying indolent prostate cancer represents a significant clinical challenge. We investigated whether integrating data from different omic platforms could identify a biomarker panel with improved performance compared to individual platforms alone. DNA methylation, transcripts, protein and glycos...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120220/ https://ncbi.nlm.nih.gov/pubmed/29927052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12348 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|